FBTvsETF 2ETF Comparison
VS
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with FBT, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FBT performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FBT ETF 2 | +1.23%– | +15.15%– | +27.12%– | +46.31%– | +72.70%– | +54.37%– |
| Flows | FBT ETF 2 | +$13M– | -$159M– | +$964M– | +$1.04B– | +$626M– | +$283M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FBT ETF 2 | +22.04%– | +21.87%– | +21.09%– | +22.20%– |
| Max drawdown | FBT ETF 2 | -4.50%– | -14.27%– | -19.92%– | -29.49%– |
| Max drawdown duration | FBT ETF 2 | 15d– | 126d– | 237d– | 1138d– |
Trading data
FBT | ETF 2 | |
Last sale 9/15/2026 at 3:37 PM | $262.76 | – |
| Previous close 09/14/2026 | $264.26 | – |
| Consolidated volume 09/14/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FBT | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Main metrics
Last update 9/15/2026 at 3:37 PM
Live
Closed
FBT | ETF 2 | |
|---|---|---|
| Last price | $262.76 | – |
| 1D performance | -0.57% | – |
| AuM | $2.85 B | – |
| E/R | 0.54% | – |
Characteristics
FBT | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | First Trust | – |
| Benchmark | NYSE Arca Biotechnology Index | – |
| N° of holdings | 30 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 19, 2006 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
FBT
USA
82.19%
Other
17.81%
ETF 2
Sectors
FBT
Healthcare
99.86%
Other
0.14%
ETF 2
Advertisement
Diversification
FBT
Total weight of top 15 holdings out of 15
55.87%
ETF 2
–
Top 15 holdings
Data as of July 31, 2026
FBT
Halozyme Therapeutics, Inc.
4.31%
Corcept Therapeutics, Inc.
4.08%
Repligen Corp.
3.87%
Regeneron Pharmaceuticals, Inc.
3.85%
BeOne Medicines Ltd.
3.83%
BioNTech SE
3.75%
Natera, Inc.
3.73%
Amgen, Inc.
3.70%
argenx SE
3.66%
NeoGenomics, Inc.
3.63%
Genmab A/S
3.57%
BioMarin Pharmaceutical, Inc.
3.55%
Illumina, Inc.
3.47%
Vertex Pharmaceuticals, Inc.
3.45%
Gilead Sciences, Inc.
3.42%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about FBT
Advertisement
